Skip to main content

Find Clinical Trials

Home
Conditions
Huntington Disease

Clinical trial condition

Huntington Disease

Explore clinical trials studying Huntington Disease. Study availability and eligibility vary by location and protocol.

226 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Huntington Disease trial results

Completed

A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan

NCT00788047

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +15 more
Locations: Pfizer Investigational Site New Haven, Connecticut, United States

View Trial Details

Completed

Family Health After Predictive Huntington Disease (HD) Testing

NCT00075140

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: The University of Iowa College of Nursing Iowa City, Iowa, United States

View Trial Details

Completed

Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease

NCT00095355

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

Treatment of Huntington's Chorea With Amantadine

NCT00001930

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease

NCT00387270

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: Huntington Study Group Rochester, New York, United States

View Trial Details

Completed

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

NCT00146211

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +23 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic Arizona Scottsdale, Arizona, United States

University of California San Diego La Jolla, California, United States

UCLA Medical Center Los Angeles, California, United States

View all 41 locations

View Trial Details

Completed

Creatine Therapy for Huntington's Disease

NCT00026988

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: Steven Hersch, M.D., Ph.D. Boston, Massachusetts, United States

Andrew Feigin, M.D. Long Island City, New York, United States

Karen Marder, M.D. New York, United States

Peter Como, Ph.D. Rochester, New York, United States

View Trial Details

Completed

Efficacy and Safety of Tetrabenazine in Chorea

NCT00219804

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Long-Term Study of Cerebral Glucose Metabolism in Huntington's Disease

NCT00004753

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +20 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

NCT07213648

Conditions: Anxiety Disorders, Basal Ganglia Diseases, Brain Diseases, +17 more
Locations: Univeristy of Virginia School of Nursing Charlottesville, Virginia, United States

View Trial Details